CIK 0001372299
- Non-accelerated filer
- Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Open-market sale Chief Executive Officer sold 100,000 shares at $1.66 ($166,000)
- 4 Open-market sale Director sold 4,500 shares at $1.83 ($8,235)
- 4 Open-market sale Director sold 42,000 shares at $2.91 ($122,220)
- 4 Open-market sale Director sold 7,500 shares at $2.57 ($19,275)
- 4 Open-market sale Chief Executive Officer sold 150,000 shares at $2.72 ($408,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 125,000 shares at $1.92 ($240,000)
- 4 Open-market sale Director sold 7,500 shares at $2.83 ($21,225)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CAO/SVP, Finance acquired 22,940 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 81,823 shares at $2.65 ($216,831)
- 4 Option exercise Director acquired 88,000 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 90,000 shares at $3.74 ($336,600)
Page 4 of 15 · 288 filings